BerryPharma AG - Strategy, SWOT and Corporate Finance Report
SummaryBerryPharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
BerryPharma AG (BerryPharma), the trademark of Iprona AG, is a manufacturer and distributor of liquid and powdered polyphenol products. The company manufactures polyphenol fruit powders, polyphenol liquids, polyphenol extract powders of red berries, such as elderberries, blackcurrants, bilberries, chokeberries (aronia), and cranberries. BerryPharma also offers customized fruit extracts based on its client requirement. Its products are offered to a number of industries including food, beverages, healthcare, cosmetics and pharmaceuticals. The company also offers marketing concept and design, packaging and logistic services. It uses various technologies such as Phenol, Infusion and Freeze concentrate technology. BerryPharma is headquartered in Lana, South Tyrol, Italy.
Scope
- Detailed information on BerryPharma AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BerryPharma AG in the form of a SWOT analysis
- An in-depth view of the business model of BerryPharma AG including a breakdown and examination of key business segments
- Intelligence on BerryPharma AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BerryPharma AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of BerryPharma AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BerryPharma AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on BerryPharma AG's business structure, strategy and prospects.
Chr. Hansen is a biosciences group based in Denmark. Co. develops and supplies natural ingredient solutions for the food, pharmaceutical, nutritional, and agricultural industries worldwide. Co. operates in three divisions: Cultures and Enzymes (develops, produces, and sells cultures, enzymes, and probiotics for the food and dairy industries); Health and Nutrition (develops products for the dietary supplement, over-the-counter pharmaceutical, infant formula, and animal feed industries); and Natural Colors (develops natural color solutions to the food industry, primarily for the beverage, dairy, confectionery, fruit preparation and ice cream, as well as functional blends for processed meats).
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.